Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

13.700
+0.3502.62%
Volume:8.37M
Turnover:114.79M
Market Cap:24.21B
PE:36.05
High:13.990
Open:13.470
Low:13.350
Close:13.350
52wk High:20.620
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.36
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.380
ROE:10.36%
ROA:3.45%
PB:2.84
PE(LYR):36.05
PS:8.26

Loading ...

Is It Time To Reassess InnoCare Pharma (SEHK:9969) After Its Strong One-Year Share Price Gain?

Simply Wall St.
·
May 08

InnoCare Pharma Maintains Stable Share Capital in April; 14.04 Million Shares Remain under Incentive Schemes

Bulletin Express
·
May 07

INNOCARE Shares Rise Nearly 3% on ASCO 2026 Oral Presentation Selection for Mesutoclax Study

Stock News
·
Apr 28

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum And Analyst Discount

Simply Wall St.
·
Apr 27

InnoCare Pharma Limited Just Missed Revenue By 19%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Apr 26

INNOCARE Calls 16 June AGM to Vote on 2026 Share Incentive Scheme, RSU Grants and Governance Amendments

Bulletin Express
·
Apr 24

Innocare Awards 15.39 Million Restricted Share Units

Stock News
·
Apr 24

InnoCare issues 15.39 million RSUs; executive portion subject to AGM vote

Bulletin Express
·
Apr 24

Stock Track | INNOCARE Soars 5.11% Intraday on Stellar Q1 2026 Results with 489% Net Profit Surge

Stock Track
·
Apr 24

Carbon Peak and Carbon Neutrality Evaluation Measures Released; Innocare Q1 Net Profit Surges 488.93%

Stock News
·
Apr 24

创新药企InnoCare 2025年度业绩显著提升,首度实现盈利并拓展多元业务布局

Bulletin Express
·
Apr 23

INNOCARE 2025 ESG Report: First-Time Profit, RMB 951.60 Million R&D Outlay and 60.75 % Carbon-Intensity Cut

Bulletin Express
·
Apr 23

InnoCare Pharma Q1 2026: Net Profit Jumps 4.9-Fold on 45% Drug-Sales Surge, Cash Pile Tops 7.92 Billion

Bulletin Express
·
Apr 23

Xie Zhiyu's Q1 Portfolio Revealed: Increased Bets on Chemical and Energy Storage Sectors

Stock News
·
Apr 21

InnoCare Pharma Sets 23 April Board Meeting to Approve Q1 2026 Unaudited Results

Bulletin Express
·
Apr 10

Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround

Simply Wall St.
·
Apr 08

Innocare Pharma Reports Annual Revenue of 23.75 Billion Yuan with 642 Million Yuan Net Profit; King Bridge Exits Entire Stake Potentially Realizing Over 2 Billion Yuan

Deep News
·
Apr 07

Goldman Sachs Slightly Raises Innocare Target to HK$19.93 on Strong Q4 Sales of Orelabrutinib

Stock News
·
Mar 30

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Mar 30

The InnoCare Pharma Limited (HKG:9969) Yearly Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.
·
Mar 28